echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Influenza helps the new crown, should develop influenza—new crown universal vaccine

    Influenza helps the new crown, should develop influenza—new crown universal vaccine

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Influenza helps the new crown, should develop influenza—new crown universal vaccine
    Influenza helps the new crown, should develop influenza-new crown universal vaccine, influenza helps the new crown, should develop influenza-new crown universal vaccine

    Recently, "Cell Research" published an online review article jointly written by Professor Jiang Shibo, Susan and Liu Zezhong at the Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Fudan University, entitled "Misfortune Does Not Come Single: Influenza Helps New Crowns" "(Double insult: flu bug enhances SARS-CoV-2infectivity), commented on a research paper published by the team of Professor Lan Ke and Xu Ke of the School of Life Sciences of Wuhan University in Cell Research.


    The research paper published by the team of Lan Ke and Xu Ke in Cell Research found that the pre-infection of influenza A virus can significantly promote the infectivity of the new coronavirus in a variety of cell types.


    Jiang Shibo and others mentioned in the review article that the continuous pandemic of the new crown epidemic and the emergence of new crown virus mutations may cause it to become an epidemic like a seasonal flu.


    At present, several multiple vaccines, such as the "diphtheria" multiple vaccine to prevent tetanus, diphtheria and pertussis, and the "mumps" multiple vaccine to prevent measles, mumps and rubella, are in clinical use.


    Previously, Jiang Shibo/Lulu’s team had published a research article in the journal Science, proving that the “agonist” cGAMP coated with bionic nanoparticles in the lungs can be used as an adjuvant for the H1N1 influenza vaccine, which can produce H1N1 in animals.


    In addition, previous research by the Jiang Shibo/Lulu team also found that a recombinant subunit protein vaccine based on RBD-Fc can induce a highly effective neutralizing antibody response to the new coronavirus and its mutant strains.


    Related paper information: org/10.


    org/10.
    1038/s41422-021-00498-6" target="_blank">https://doi.
    org/10.
    1038/s41422-021-00498-6
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.